CADESS.AI

CADESS.AI was founded in 2016 with the mission to improve patient outcome and reduce healthcare costs for prostate cancer by delivering innovative digital pathology decision support solutions... We offer CADESS™, an AI-based decision support system for hospital and commercial pathology laboratories involved in diagnosis and prognostication of prostate cancer... CADESS™ is based on state-of-the-art deep learning and imaging analysis technology and helps determine who can live with prostate cancer and who requires aggressive treatment to survive.

Registration numbers: 559083-2076 (W)

Primary location: Uppsala Sweden